Back to top
more

Teladoc Health (TDOC)

(Real Time Quote from BATS)

$12.97 USD

12.97
3,561,238

+0.16 (1.25%)

Updated May 2, 2024 03:42 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 33% (83 out of 251)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Sheraz Mian headshot

Making Sense of Tech Sector Earnings After a Big Week of Results

by Sheraz Mian

Total Q1 earnings for the 'Big 5 Tech' players are down -8.4% from the same period last year on +11.4% higher revenues, with a 421 basis-points (bps) compression in net margins

The Zacks Analyst Blog Highlights Antero Resources, Arthur J. Gallagher, Teladoc Health, W. P. Carey and Weyerhaeuser

by Zacks Equity Research

Antero Resources, Arthur J. Gallagher, Teladoc Health, W. P. Carey and Weyerhaeuser have been included in this Analyst Blog.

Teladoc (TDOC) Reports Q1 Loss, Lags Revenue Estimates

by Zacks Equity Research

Teladoc (TDOC) delivered earnings and revenue surprises of 14.55% and 0.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Nalak Das headshot

5 Stocks to Buy Ahead of Q1 Earnings Results This Week

by Nalak Das

Five companies with a favorable Zacks Rank will report first-quarter earnings results this week. These are: WPC, WY, TDOC, AR and AJG.

Teladoc (TDOC) Stock Moves -1.35%: What You Should Know

by Zacks Equity Research

In the latest trading session, Teladoc (TDOC) closed at $58.25, marking a -1.35% move from the previous day.

Teladoc (TDOC) Eyes Q1 Earnings Beat on Rising US Paid Members

by Zacks Equity Research

Teladoc Health's (TDOC) first-quarter 2022 results are likely to reflect improved subscription access fees revenues.

Teladoc (TDOC) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

Teladoc (TDOC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Teladoc (TDOC) Stock Moves -0.38%: What You Should Know

by Zacks Equity Research

Teladoc (TDOC) closed at $65.81 in the latest trading session, marking a -0.38% move from the prior day.

Teladoc (TDOC) Stock Moves -1.29%: What You Should Know

by Zacks Equity Research

In the latest trading session, Teladoc (TDOC) closed at $72.13, marking a -1.29% move from the previous day.

Why You Should Retain Teladoc Health (TDOC) Stock for Now

by Zacks Equity Research

Teladoc Health (TDOC) is focused on making strategic partnerships to boost user numbers.

Teladoc (TDOC) Up 12.6% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Teladoc (TDOC) Stock Moves -0.94%: What You Should Know

by Zacks Equity Research

In the latest trading session, Teladoc (TDOC) closed at $69.22, marking a -0.94% move from the previous day.

Teladoc Health's (TDOC) Virtual Care Model to Aid Companies

by Zacks Equity Research

Teladoc Health's (TDOC) first industry-standard model to help employers improve their package of telehealth services.

    Teladoc (TDOC) Stock Moves -0.24%: What You Should Know

    by Zacks Equity Research

    In the latest trading session, Teladoc (TDOC) closed at $63.55, marking a -0.24% move from the previous day.

    Teladoc Health (TDOC) Tumbling: Is it Healthy for Your Portfolio?

    by Zacks Equity Research

    For this year, Teladoc Health (TDOC) projects total visits in the band of 18.5-20 million, indicating a rise from the 2021 level of 15.4 million.

    Stock Market News for Mar 1, 2022

    by Zacks Equity Research

    U.S. stocks market closed mixed on Monday, the last trading day of February.

    Teladoc Health (TDOC), Amazon Tie Up to Advance Virtual Care

    by Zacks Equity Research

    Teladoc Health (TDOC) collaborates with Amazon so that customers can avail quick and effective virtual care medical services via their Alexa-activated intelligent speakers.

    Teladoc (TDOC) Q4 Loss Narrows on Higher Visits, Memberships

    by Zacks Equity Research

    Teladoc (TDOC) projects 2022 total visits in the band of 18.5-20 million, indicating an uptick from the 2021 level of 15.4 million.

    Teladoc (TDOC) Reports Q4 Loss, Tops Revenue Estimates

    by Zacks Equity Research

    Teladoc (TDOC) delivered earnings and revenue surprises of 88.14% and 1.09%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

    The Zacks Analyst Blog Highlights Teladoc Health, Albireo Pharma and The Joint Corp

    by Zacks Equity Research

    Teladoc Health, Albireo Pharma and The Joint Corp are included in this blog.

    Teladoc (TDOC) Unveils Solution to Ease Whole-Person Care

    by Zacks Equity Research

    Teladoc Health (TDOC) launches Chronic Care Complete for extending a comprehensive suite of chronic condition management services for serving the whole-person health needs of eligible members.

    Is a Surprise Coming for Teladoc (TDOC) This Earnings Season?

    by Zacks Equity Research

    Teladoc (TDOC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

    What's in Store for Teladoc's (TDOC) Q4 Earnings?

    by Zacks Equity Research

    Teladoc Health's (TDOC) Q4 results are expected to gain from high sales and visits volume.

    How Investors Can Grab Better Returns for Medical Using the Zacks ESP Screener

    by Zacks Equity Research

    Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

    Teladoc (TDOC) Expected to Beat Earnings Estimates: Should You Buy?

    by Zacks Equity Research

    Teladoc (TDOC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.